Alterome Therapeutics, Inc.

About Alterome Therapeutics, Inc.

Alterome Therapeutics is a clinical-stage biotechnology company focused on transforming the lives of cancer patients by discovering precise therapies and inspiring hope. Their mission is driven by urgency and guided by core values of accountability, creativity, perseverance, longevity, compassion, and co-elevation.

Products & Services

Platform:A drug discovery platform powered by computational chemistry and structure-guided approaches to develop targeted oncology therapies.

Programs:Clinical programs targeting high-value oncogenic drivers like AKT and KRAS with first-in-class small molecule therapies for cancer patients with limited treatment options.

Specialties

Precision Oncology Drug Discovery Targeted Therapies Computational Chemistry Structure-Guided Drug Design Oncogenic Targets (AKT, KRAS)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 132000000 MR: - FA: $132 million FAN: 132000000	D: 2024-04-03 FD: 2024-04-03	11 investors

Series B Latest

2024-04-03

$132.0M

11 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jung Choi

CEO

S

Scott Moorefield

COO & CBO

A

Andrew Chi

CMO

M

Michael Bartberger

SVP, Discovery Research

J

Jonathan Tran

SVP, Clinical Pharmacology & Nonclinical Development

A

Aziz Alam

VP, Regulatory Affairs

View 56 more team members with Pro

Unlock Full Team Directory

Recent News